Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1996 Dec;40(12):2874–2878. doi: 10.1128/aac.40.12.2874

Antimicrobial susceptibility patterns of some recently established coryneform bacteria.

G Funke 1, V Pünter 1, A von Graevenitz 1
PMCID: PMC163638  PMID: 9124857

Abstract

The susceptibility patterns of 480 isolates representing six recently defined species of coryneform bacteria (Corynebacterium amycolatum [n = 101], Corynebacterium auris [n = 48], Corynebacterium glucuronolyticum [n = 86], Brevibacterium casei [n = 50], Dermabacter hominis [n = 49], and Turicella otitidis [n = 146]) to 17 antimicrobial agents were determined by an agar dilution method. Most significantly, for C. amycolatum strains the MICs at which 90% of isolates are inhibited were > or = 32 micrograms/ml for nearly all agents. However, all 480 strains examined were susceptible to glycopeptide antibiotics.

Full Text

The Full Text of this article is available as a PDF (216.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barreau C., Bimet F., Kiredjian M., Rouillon N., Bizet C. Comparative chemotaxonomic studies of mycolic acid-free coryneform bacteria of human origin. J Clin Microbiol. 1993 Aug;31(8):2085–2090. doi: 10.1128/jcm.31.8.2085-2090.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barry A. L., Pfaller M. A., Fuchs P. C., Tenover F. C., Reller L. B., Allen S. D., Hardy D. J., Gerlach E. H. Interpretive criteria and quality control parameters for determining bacterial susceptibility to fosfomycin tromethamine. Eur J Clin Microbiol Infect Dis. 1993 May;12(5):352–356. doi: 10.1007/BF01964433. [DOI] [PubMed] [Google Scholar]
  3. Coyle M. B., Lipsky B. A. Coryneform bacteria in infectious diseases: clinical and laboratory aspects. Clin Microbiol Rev. 1990 Jul;3(3):227–246. doi: 10.1128/cmr.3.3.227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Funke G., Carlotti A. Differentiation of Brevibacterium spp. encountered in clinical specimens. J Clin Microbiol. 1994 Jul;32(7):1729–1732. doi: 10.1128/jcm.32.7.1729-1732.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Funke G., Lawson P. A., Bernard K. A., Collins M. D. Most Corynebacterium xerosis strains identified in the routine clinical laboratory correspond to Corynebacterium amycolatum. J Clin Microbiol. 1996 May;34(5):1124–1128. doi: 10.1128/jcm.34.5.1124-1128.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Funke G., Lawson P. A., Collins M. D. Heterogeneity within human-derived centers for disease control and prevention (CDC) coryneform group ANF-1-like bacteria and description of Corynebacterium auris sp. nov. Int J Syst Bacteriol. 1995 Oct;45(4):735–739. doi: 10.1099/00207713-45-4-735. [DOI] [PubMed] [Google Scholar]
  7. Funke G., Stubbs S., Altwegg M., Carlotti A., Collins M. D. Turicella otitidis gen. nov., sp. nov., a coryneform bacterium isolated from patients with otitis media. Int J Syst Bacteriol. 1994 Apr;44(2):270–273. doi: 10.1099/00207713-44-2-270. [DOI] [PubMed] [Google Scholar]
  8. Funke G., Stubbs S., Pfyffer G. E., Marchiani M., Collins M. D. Characteristics of CDC group 3 and group 5 coryneform bacteria isolated from clinical specimens and assignment to the genus Dermabacter. J Clin Microbiol. 1994 May;32(5):1223–1228. doi: 10.1128/jcm.32.5.1223-1228.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gruner E., Pfyffer G. E., von Graevenitz A. Characterization of Brevibacterium spp. from clinical specimens. J Clin Microbiol. 1993 Jun;31(6):1408–1412. doi: 10.1128/jcm.31.6.1408-1412.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kaukoranta-Tolvanen S. S., Sivonen A., Kostiala A. A., Hormila P., Vaara M. Bacteremia caused by Brevibacterium species in an immunocompromised patient. Eur J Clin Microbiol Infect Dis. 1995 Sep;14(9):801–804. doi: 10.1007/BF01690997. [DOI] [PubMed] [Google Scholar]
  11. Lina B., Carlotti A., Lesaint V., Devaux Y., Freney J., Fleurette J. Persistent bacteremia due to Brevibacterium species in an immunocompromised patient. Clin Infect Dis. 1994 Mar;18(3):487–488. doi: 10.1093/clinids/18.3.487. [DOI] [PubMed] [Google Scholar]
  12. Lortholary O., Buu-Hoï A., Fagon J. Y., Pierre J., Slama M., Gutmann L., Acar J. F. Mediastinitis due to multiple resistant Corynebacterium xerosis. Clin Infect Dis. 1993 Jan;16(1):172–172. doi: 10.1093/clinids/16.1.172. [DOI] [PubMed] [Google Scholar]
  13. Roberts M. C., Leonard R. B., Briselden A., Schoenknecht F. D., Coyle M. B. Characterization of antibiotic-resistant Corynebacterium striatum strains. J Antimicrob Chemother. 1992 Oct;30(4):463–474. doi: 10.1093/jac/30.4.463. [DOI] [PubMed] [Google Scholar]
  14. Schiller J., Groman N., Coyle M. Plasmids in Corynebacterium diphtheriae and diphtheroids mediating erythromycin resistance. Antimicrob Agents Chemother. 1980 Nov;18(5):814–821. doi: 10.1128/aac.18.5.814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Soriano F., Zapardiel J., Nieto E. Antimicrobial susceptibilities of Corynebacterium species and other non-spore-forming gram-positive bacilli to 18 antimicrobial agents. Antimicrob Agents Chemother. 1995 Jan;39(1):208–214. doi: 10.1128/aac.39.1.208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Tauch A., Kassing F., Kalinowski J., Pühler A. The Corynebacterium xerosis composite transposon Tn5432 consists of two identical insertion sequences, designated IS1249, flanking the erythromycin resistance gene ermCX. Plasmid. 1995 Sep;34(2):119–131. doi: 10.1006/plas.1995.9995. [DOI] [PubMed] [Google Scholar]
  17. Tumbarello M., Tacconelli E., Del Forno A., Caponera S., Cauda R. Corynebacterium striatum bacteremia in a patient with AIDS. Clin Infect Dis. 1994 Jun;18(6):1007–1008. doi: 10.1093/clinids/18.6.1007. [DOI] [PubMed] [Google Scholar]
  18. Van Bosterhaut B., Cuvelier R., Serruys E., Pouthier F., Wauters G. Three cases of opportunistic infection caused by propionic acid producing Corynebacterium minutissimum. Eur J Clin Microbiol Infect Dis. 1992 Jul;11(7):628–631. doi: 10.1007/BF01961672. [DOI] [PubMed] [Google Scholar]
  19. Wallet F., Marquette C. H., Courcol R. J. Multiresistant Corynebacterium xerosis as a cause of pneumonia in a patient with acute leukemia. Clin Infect Dis. 1994 May;18(5):845–846. doi: 10.1093/clinids/18.5.845. [DOI] [PubMed] [Google Scholar]
  20. Wichmann S., Wirsing von Koenig C. H., Becker-Boost E., Finger H. Isolation of Corynebacterium group JK from clinical specimens with a semiselective medium. J Clin Microbiol. 1984 Feb;19(2):204–206. doi: 10.1128/jcm.19.2.204-206.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Zapardiel J., Nieto E., Gegúndez M. I., Gadea I., Soriano F. Problems in minimum inhibitory concentration determinations in coryneform organisms. Comparison of an agar dilution and the Etest. Diagn Microbiol Infect Dis. 1994 Jul;19(3):171–173. doi: 10.1016/0732-8893(94)90062-0. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES